In patients with HBV-related HCC, GP73 had higher sensitivity, specificity, and AUROC than α-FP (87.1%, 83.9%, and 92% vs. 48.4%, 96.8%, and 77%, respectively) [60]. Here, GOLM1 is linked to hepatocellular carcinoma.